Mice with missense and nonsense NF1 mutations display divergent phenotypes compared to NF1 patients
Open Access
- 1 January 2016
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 9 (7) , 759-767
Abstract
Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by the occurrence of nerve sheath tumors and considerable clinical heterogeneity. Some translational studies have been limited by the lack of animal models assessing patient-specific mutations. In order to test therapeutic approaches that may restore function to the mutated gene or gene product, we developed mice harboring NF1 patient-specific mutations including a nonsense mutation (c.2041C>T; p.Arg681*) and a missense mutation (c.2542G>C; p.Gly848Arg). The latter are associated with the development of multiple plexiform neurofibromas along spinal nerve roots. We demonstrate that the human nonsense NF1Arg681* and missense NF1Gly848Arg mutations have different effects in the mouse on neurofibromin expression and each recapitulates unique aspects of the NF1 phenotype, depending upon the genetic context when assessed in the homozygous state or when paired with a conditional knockout allele. Whereas the missense Nf1Gly848Arg mutation fails to produce an overt phenotype in the mouse, animals homozygous for the nonsense Nf1Arg681* mutation are not viable. Mice with one Nf1Arg681*allele in combination with a conditional floxed Nf1 allele and the DhhCre transgene (Nf14F/Arg681*; DhhCre) display disorganized nonmyelinating axons and neurofibromas along the spinal column, which leads to compression of the spinal cord and paralysis. This model will be valuable for novel preclinical testing of nonsense suppression therapies using drugs to target in-frame point mutations that create premature termination codons in patients with NF1.Keywords
Funding Information
- University of Alabama at Birmingham Neurofibromatosis Program
- Children's Tumor Foundation
This publication has 41 references indexed in Scilit:
- Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense SuppressionPLOS ONE, 2013
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumorsJournal of Clinical Investigation, 2012
- Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1splice-site mutations?Human Genomics, 2012
- The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouseMolecular Genetics and Metabolism, 2012
- Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOHHuman Mutation, 2010
- Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Human Molecular Genetics, 2009
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone MarrowCell, 2008
- Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing CellsCancer Cell, 2008
- A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticinProceedings of the National Academy of Sciences, 2007
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006